Sixty-third session

Vienna, Austria, 2-6 March 2020

COVID-19 Virus :  

          -  Meeting guidelines

          -  Cough etiquette

          -  27 February 2020: Message by the Deputy Director-General of UNOV on COVID-19

Information for Participants

Programme

Side Events / Report

Statements

List of Participants

Journals

Presentations

Draft proposals 

In-session draft reports

General information on draft resolutions and draft decisions

Webcast

NOTE: As part of the Secretariat's efforts to reduce expenditure and limit environmental impact through the digitization of conference materials and publications, pre-session documents of the 63 rd session will only be issued electronically. 

Participants who wish to use printed versions of the pre-session documents are  kindly requested to bring their own copies of the pre-session documents to the meeting.                                                                                                                                     

 

Document Symbol                       

Title or description

E/CN.7/2020/1

Provisional agenda, annotations and proposed organization of work

E/CN.7/2020/2-E/CN.15/2020/2

Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime 

E/CN.7/2020/3-E/CN.15/2020/3

Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime

E/CN.7/2020/4

Report of the Secretariat on the world situation with regard to drug abuse

E/CN.7/2020/5

Report of the Secretariat on the world situation with regard to drug trafficking

E/CN.7/2020/6

Report of the Executive Director on actions taken by Member States to implement the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem 

E/CN.7/2020/7

Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS 

E/CN.7/2020/8

Report of the Executive Director on responding to the prevalence of HIV/AIDS and other blood-borne diseases among drug users

E/CN.7/2020/9

Report of the Secretariat on action by the subsidiary bodies of the Commission on Narcotic Drugs

E/CN.7/2020/10

Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations by WHO

E/CN.7/2020/11

Note by the Secretariat on the scope of control of substances under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 concerning the proposed scheduling of methyl alpha-phenylacetoacetate (MAPA) under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 

E/CN.7/2020/12

Note by the Secretariat on the improved and streamlined Annual Report Questionnaire (ARQ)  

E/CN.7/2020/13-E/CN.15/2020/15

Note by the Secretariat on the draft proposed programme plan for 2021 and performance information for 2019 

E/CN.7/2020/14

Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations on cannabis and cannabis-related substances 

 

 

E/CN.7/2020/CRP.1

Chair's summary by H.E. Ambassador Mirghani Abbaker Altayeb Bakhet (Sudan), Chair of the sixty-second session of the Commission on Narcotic Drugs, on the thematic discussions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration (16-18 October 2019) 

E/CN.7/2020/CRP.2

Note by the Secretariat on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration 

E/CN.7/2020/CRP.3*

Guidelines for the completion of the annual report questionnaire (ARQ) 

E/CN.7/2020/CRP.4

Compilation of all questions and answers on the WHO recommendations on cannabis and cannabis-related substances raised during the fourth and fifth intersessional meeting of the Commission at its sixty-second session 

E/CN.7/2020/CRP.5

Note by the Secretariat on inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem 

E/CN.7/2020/CRP.6

UNODC/WHO International Standards for the Treatment of Drug Use Disorders

E/CN.7/2020/CRP.7

Conference Room Paper submitted jointly by Germany, Peru, Thailand and UNODC titled, "Advancing Alternative Development and Development-oriented Drug Policies" 

E/CN.7/2020/CRP.8 

Strengthening international cooperation in combating illicit
opiates originating in Afghanistan through continuous and
reinforced support to the Paris Pact initiative 

E/CN.7/2020/CRP.9

Changes in the scope of control of substances: proposed

scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances  

E/CN.7/2020/CRP.10

Changes in the scope of control of substances: proposed

scheduling recommendations by the World Health Organization 

E/CN.7/2020/CRP.11

Note of the Secretariat on the implementation of resolution 61/11 "Promoting non-stigmatizing attitudes to ensure the availability of, access to and delivery of health, care and social services"

E/CN.7/2020/CRP.12

UNODC Handbook on Youth Participation in Drug Prevention Work

E/CN.7/2020/CRP.13

Conference room paper submitted by the International Narcotics Control Board, titled: "Option to address the proliferation of non-scheduled chemicals, including designer precursors - contribution to a wider policy dialogue"

E/CN.7/2020/CRP.14

Reports by intergovernmental organizations on drug control activities 

E/CN.7/2020/CRP.15

Priority activities to support data collection and analysis related to drugs at the national level (Report prepared by the Research and Trend Analysis Branch of UNODC) 

E/CN.7/2020/CRP.16

Conference room paper submitted by Turkey "Expert Group Meeting on Innovative Methods to Track Precursor Chemicals, 26-27 November 2019, Antalya"  

 

 

E/2020/28 - E/CN.7/2020/15

Commission on Narcotic Drugs, Report on its sixty-third session 

E/CN.7/2020/CRP.17

Statements of financial implications in connection with the adoption of draft resolutions

E/CN.7/2020/CRP.18

List of documents before the Commission at its sixty-second session

NGO Papers

Document Symbol

Title or description

E/CN.7/2020/NGO/1

Statement submitted by Asociación Proyecto Hombre, a non-governmental organization in consultative status with the Economic and Social Council

E/CN.7/2020/NGO/2 

Statement submitted by Dianova International, a non-governmental organization in consultative status with the Economic and Social Council

E/CN.7/2020/NGO/3  

Statement submitted by the Canadian Centre on Substance Abuse, a non-governmental organization with consultative status with the Economic and Social Council

E/CN.7/2020/NGO/4

Statement submitted by the Canadian HIV/AIDS Legal Network, a non-governmental organization in consultative status with the Economic and Social Council

E/CN.7/2020/NGO/5

Statement submitted by the International Drug Policy Consortium, a non-governmental organization in consultative status with the Economic and Social Council

E/CN.7/2020/NGO/6

Statement submitted by Grupo de Mujeres de la Argentina -Foro de VIH, mujeres y familia, a non-governmental organization in consultative status with the Economic and Social Council 

Additional/Background documents

Document Symbol

Title or description

Arabic

Chinese

English

French

Russian 

Spanish

Implementation of all international drug policy commitments:

- Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem" (2019)

- Outcome document of the thirtieth special session of the General Assembly, entitled "Our joint commitment to effectively addressing and countering the world drug problem" (2016)

- Joint Ministerial Statement of the 2014 High-level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem (2014)

- Political Declaration and Plan of Action on International Cooperation towards and Integrated and Balanced Strategy to Counter the World Drug Problem (2009)